Future Aranesp Discounts Would Respond To Procrit Price Changes, Amgen Says

First quarter Aranesp pricing adjustments were Amgen’s answer to J&J’s new Procrit clinic contracts. Since the February price changes, Aranesp market share has grown five points, Amgen says.

More from Archive

More from Pink Sheet